Rubi, a carbon-to-materials manufacturing company, announced it has raised $7.5 million in new funding as it accelerates the commercialization of its platform that converts CO2 into essential materials. The company also disclosed it has secured more than $60 million in multi-year offtake term sheets with leading fashion brands and manufacturers, signaling growing demand for its technology.
The funding round was co-led by AP Ventures and FH One Investments, with participation from Talis Capital, CMPC Ventures, H&M Group, Understorey Ventures, and a group of angel investors. Rubi said the capital will be used to scale its production system to industrial demonstration, expand its product pipeline, and enhance its engineered enzyme capabilities to improve performance and reduce costs.
The announcement follows a year of commercial momentum for the company. In 2025, Rubi signed over $60 million in offtake agreements, expanded its commercial partnerships from seven to 15, and completed fiber performance testing with multiple partners. The company also launched new pilot programs with partners in consumer packaged goods and aerospace, broadening its reach beyond textiles.
Rubi’s technology uses a proprietary cell-free enzyme platform to convert carbon molecules such as CO2 into complex materials like cellulose polymers. Unlike traditional manufacturing processes that rely on large-scale infrastructure, Rubi’s modular system is designed to be deployed anywhere, enabling localized production with significantly lower capital requirements. The company claims its approach can reduce capital expenditures by up to 10 times compared to conventional methods.
The company is now advancing toward industrial-scale demonstration, aiming to produce commercial quantities of materials for customers across textile and consumer product applications. Rubi also strengthened its scientific advisory board in 2025, adding experts in biocatalysis, AI-driven enzyme engineering, and scalable cell-free systems.
Founded in 2021, Rubi is positioning its platform as a more flexible and sustainable alternative to traditional manufacturing, with applications spanning textiles, chemicals, aerospace, and consumer goods.
KEY QUOTES
“We started Rubi with the vision that cell-free, multi-enzyme pathways would unlock efficient, scalable, high-performance manufacturing for critical materials from CO2. We’ve now demonstrated this technology scales effectively and meets or exceeds customer product standards, driving an inflection point of commercialization. The fresh funding will accelerate our scaling and growth to meet strong global demand for modular and affordable manufacturing of essential materials from waste carbon across textile, CPG, aerospace, and chemicals verticals.”
Neeka Mashouf, Co-Founder And CEO Of Rubi
“Rubi has reached an important transition point, with its technology now demonstrated at pilot scale and clear demand emerging across multiple end markets. The team has made strong progress translating a differentiated scientific platform into early commercial traction. We’re pleased to support Rubi as it moves into industrial demonstration and the next phase of scaling.”
Kevin Eggers, Partner At AP Ventures
